Nanoform Finland Oyj (HEL:NANOFH)

Market Cap	83.01M +16.2%
Revenue (ttm)	5.53M +39.8%
Net Income	-13.74M
EPS	-0.16
Shares Out	85.75M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25,774
Open	0.9650
Previous Close	0.9680
Day's Range	0.9490 - 0.9650
52-Week Range	0.3770 - 1.3820
Beta	0.78
Analysts	Strong Buy
Price Target	2.13 (+122.8%)
Earnings Date	Aug 20, 2026

About Nanoform Finland Oyj

Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies, formulation, and analytical services, including controlled expansion of supercritical solutions technology that enables the creation of active pharmaceutical ingredients (API) nanoparticles directly from solution; biological nanoforming technology; and dosage forms of Nanoparticles. It also offers STARMAP, an AI platform predic...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 108
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: NANOFH

Financial Performance

In 2025, Nanoform Finland Oyj's revenue was 5.02 million, an increase of 37.10% compared to the previous year's 3.66 million. Losses were -17.90 million, -23.60% less than in 2024.

Analyst Summary

According to 2 analysts, the average rating for NANOFH stock is "Strong Buy." The 12-month stock price target is €2.13, which is an increase of 122.80% from the latest price.

Price Target

€2.13

(122.80% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 2, 2026

Data Sources Report a data error